Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-20-136547

Options or other derivatives

  • Chief Financial Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Bellemin Jean-Marc Chief Financial Officer 2020-12-14 Grant or award · Stock Option (right to buy) +150,000 150,000 D
Loading xslF345X03/tm2038660d2_4.xml…